Search for: "Janssen Alzheimer Immunotherapy" Results 1 - 3 of 3
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Jul 2012, 5:56 pm by Linda Moss
guid=20120723006412en&source=RSS_2011&page=1 Pfizer and Johnson & Johnson, via its Janssen AI unit, are partners in the Alzheimer’s Immunotherapy Program (AIP). [read post]
7 Aug 2012, 9:59 pm by Linda Moss
On Monday Pfizer said that  the co-primary clinical endpoints, change in cognitive and functional performance compared to placebo, were not met in J&J’s Janssen Alzheimer Immunotherapy R&D LLC -led Phase 3 trial of intravenous bapineuzumab in patients with mild-to-moderate Alzheimer’s disease who do not carry the ApoE4 (apolipoprotein E epsilon 4) genotype, which is a marker for the disease. [read post]
26 Jun 2013, 6:43 am
  The citation is EliLilly & Company v Janssen Alzheimer Immunotherapy [2013] EWHC 1737 (Pat) (25 June 2013) and you can read it in full on the ever-faithful BAILII, complete with pretty pictures. [read post]